US Patent 11248030 Dual IL-2R and IL-7R binding compounds
Patent 11248030 was granted and assigned to Medikine on February, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 6 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+355 characters)
Article
Patent abstract
Dual receptor binding compounds comprising IL-2Rβ, IL-7Rα, and Rγc ligands, and pharmaceutical compositions comprising the dual receptor binding compounds are disclosed. The dual receptor binding compounds can act as IL-2R and IL-7R agonists and are useful in treating cancer, viral diseases, autoimmune diseases, and inflammatory diseases.
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Alice V. Bakker0
Michael C. Needels0
Ronald W. Barrett0
Steven E. Cwirla0
William J. Dower0
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 16 Feb, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
US Patent 11248030 Dual IL-2R and IL-7R binding compounds
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11248030
Date of patent
February 15, 2022
Patent application number
17089533
Date Filed
November 4, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11248030 Dual IL-2R and IL-7R binding compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
